[go: up one dir, main page]

NO20063686L - Anvendelse av o-ATP for behandling av sykdommer omfattende angiogenese - Google Patents

Anvendelse av o-ATP for behandling av sykdommer omfattende angiogenese

Info

Publication number
NO20063686L
NO20063686L NO20063686A NO20063686A NO20063686L NO 20063686 L NO20063686 L NO 20063686L NO 20063686 A NO20063686 A NO 20063686A NO 20063686 A NO20063686 A NO 20063686A NO 20063686 L NO20063686 L NO 20063686L
Authority
NO
Norway
Prior art keywords
atp
treatment
diseases including
including angiogenesis
angiogenesis
Prior art date
Application number
NO20063686A
Other languages
English (en)
Norwegian (no)
Inventor
Maria Elena Ferrero
Original Assignee
Univ Degli Studi Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Milano filed Critical Univ Degli Studi Milano
Publication of NO20063686L publication Critical patent/NO20063686L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Toilet Supplies (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20063686A 2004-02-17 2006-08-16 Anvendelse av o-ATP for behandling av sykdommer omfattende angiogenese NO20063686L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000255A ITMI20040255A1 (it) 2004-02-17 2004-02-17 Sostanze ad attivita' antiangiogenica
PCT/EP2005/001458 WO2005077383A1 (en) 2004-02-17 2005-02-14 The use of o-atp for the treatment of diseases involving angiogenesis

Publications (1)

Publication Number Publication Date
NO20063686L true NO20063686L (no) 2006-08-16

Family

ID=34856914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063686A NO20063686L (no) 2004-02-17 2006-08-16 Anvendelse av o-ATP for behandling av sykdommer omfattende angiogenese

Country Status (16)

Country Link
US (1) US20070099864A1 (es)
EP (1) EP1732574B1 (es)
JP (1) JP2007522177A (es)
KR (1) KR20070007786A (es)
CN (1) CN1917887A (es)
AT (1) ATE456371T1 (es)
AU (1) AU2005211924A1 (es)
BR (1) BRPI0507738A (es)
CA (1) CA2556601A1 (es)
DE (1) DE602005019142D1 (es)
ES (1) ES2336011T3 (es)
IT (1) ITMI20040255A1 (es)
NO (1) NO20063686L (es)
PL (1) PL1732574T3 (es)
RU (1) RU2359679C2 (es)
WO (1) WO2005077383A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2417758C1 (ru) * 2009-10-21 2011-05-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Способ оценки эффективности противоопухолевой терапии при нейробластомах у детей
FR3041260B1 (fr) * 2015-09-21 2020-10-02 Hopitaux Paris Assist Publique Utilisation d'un tripeptide cyclique pour stimuler l'activite mitochondriale de cellules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324731A (en) * 1989-02-14 1994-06-28 Amira, Inc. Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated
IT1318667B1 (it) * 2000-08-04 2003-08-27 Univ Degli Studi Milano Medicamento antinfiammatorio.
PA8557501A1 (es) * 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) * 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
US20050053612A1 (en) * 2003-08-20 2005-03-10 Granstein Richard D. Nucleotide regulation of immune responses

Also Published As

Publication number Publication date
PL1732574T3 (pl) 2010-07-30
ITMI20040255A1 (it) 2004-05-17
AU2005211924A1 (en) 2005-08-25
CA2556601A1 (en) 2005-08-25
DE602005019142D1 (de) 2010-03-18
ATE456371T1 (de) 2010-02-15
JP2007522177A (ja) 2007-08-09
ES2336011T3 (es) 2010-04-07
EP1732574A1 (en) 2006-12-20
WO2005077383A1 (en) 2005-08-25
CN1917887A (zh) 2007-02-21
RU2006129748A (ru) 2008-02-27
EP1732574B1 (en) 2010-01-27
KR20070007786A (ko) 2007-01-16
US20070099864A1 (en) 2007-05-03
BRPI0507738A (pt) 2007-07-10
RU2359679C2 (ru) 2009-06-27

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
ATE448232T1 (de) Substituierte heterozyklen
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
UA85559C2 (en) Aminobenzophenone compounds
NI200600319A (es) Antagonistas de ccr2 de sal cuaternaria
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
NL1026327A1 (nl) 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten.
ECSP055964A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6
PL1708991T3 (pl) Pochodne sulfonoamidu do leczenia chorób
NL1026203A1 (nl) Verbindingen toepasbaar voor de behandeling van ziekten.
ATE424386T1 (de) Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten
NO20082425L (no) Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.
SE0302304D0 (sv) Novel compounds
ATE380188T1 (de) Substituierte chinolone
NO20063686L (no) Anvendelse av o-ATP for behandling av sykdommer omfattende angiogenese
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
ATE399532T1 (de) Medizinische seife
MXPA05012696A (es) Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica.
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application